Sangtech Lab unveils solvent-free blood filter made without process wastewater
Sangtech Lab says its CellNet PR is the first commercial whole blood inline leukoreduction filter made without organic solvents or process wastewater. The Taiwan-based company says the product pairs that manufacturing process with DEHP-free materials and award recognition from Edison and R&D 100.
Why it matters: - Sangtech Lab says CellNet PR removes two environmental burdens from blood filter manufacturing: organic solvents and process wastewater. - The company is positioning the filter as a sustainability upgrade for blood services that want lower upstream environmental impact without changing transfusion safety goals. - CellNet PR is also offered with DEHP-free housing and media, which matters for materials safety and regulatory pressure on medical devices.
What happened: - Sangtech Lab announced CellNet PR on November 17, 2026, in Taipei. - The company described CellNet PR as the world’s first and only commercial whole blood inline leukoreduction filter made without organic solvents or process wastewater. - Sangtech Lab said the product is manufactured through a patented supercritical-CO₂ process rather than conventional solvent-based wet chemistry.
The details: - The company says the process runs in a closed supercritical-CO₂ system where CO₂ is recovered and reused. - Sangtech Lab said the manufacturing process uses no organic solvents and no process water at any stage. - The company reported a gate-to-gate carbon footprint of 7.68 kg CO₂e per kilogram of filtration media. - CellNet PR is available with zero-DEHP housing in hard and soft casing formats, plus DEHP-free media. - Sangtech Lab said the filter media enables leukoreduction to fewer than 0.3×10⁶ residual white cells per unit. - The company said red cell recovery is above 92%. - Sangtech Lab said the product meets ISO 10993-5 cytotoxicity grade 0 and has no solvent residuals to extract. - The company said the filter removes 98% to 100% of platelets without activating them. - Sangtech Lab supplies CellNet filter media and semi-finished filters to medical device manufacturers and research institutions worldwide from an ISO 13485 facility in Yilan, Taiwan.
Between the lines: - The announcement is as much about manufacturing method as product performance. - Sangtech Lab is trying to reframe leukoreduction filters as a supply-chain sustainability issue, not just a clinical one. - The company also appears to be using third-party recognition to validate its environmental claims, citing a 2026 Edison Award and a 2026 R&D 100 Award. - Sangtech Lab’s “world’s first and only” claim is based on its review of commercial whole-blood leukoreduction filters across major markets.
What's next: - Sangtech Lab said it will continue supplying the media and semi-finished filters to manufacturers that integrate them into finished medical devices. - Finished-device performance and regulatory clearance remain the responsibility of the integrating manufacturer. - The company also said it welcomes documented evidence if another commercial whole-blood leukoreduction filter is manufactured the same way.
The bottom line: - Sangtech Lab is betting that blood-filter buyers will value a solvent-free, water-free manufacturing process as much as clinical performance.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Environmental News Watch
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.